Lyra Therapeutics has filed a notice of an exempt offering of securities to raise $50,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Lyra Therapeutics is raising $50,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Maria Palasis played a…